Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Neeson

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Haematologica|June 19, 2009
The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cellsPatries M Herst, Joanne E Davis, Paul Neeson, et al.
Virology|August 15, 2006
A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotypePaul Neeson, Jean Boyer, Sanjeev Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in miceJoanne E Davis, Michael Harvey, Nicholas A Gherardin, et al.
Cancers|June 18, 2020
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient SurvivalDonald Freudenstein, Cassandra Litchfield, Franco Caramia, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Immunological responses to brain metastasis stereotactic radiosurgery in patient-matched longitudinal blood and tumour samplesJoseph Sia, Criselle D'Souza, Becky Castle, et al.
Journal of Personalized Medicine|November 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision TherapeuticsJoshua M L Casan, Xiao Jing Ong, Carrie van der Weyden, et al.
Blood|October 28, 2010
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapyAndy K Hsu, Hang Quach, Tsin Tai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2014
Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone lossJulie M Quach, Maria Askmyr, Tanja Jovic, et al.
Oral Oncology|December 16, 2019
Validation and characterisation of prognostically significant PD-L1<sup>+</sup> immune cells in HPV+ oropharyngeal squamous cell carcinomaRichard J Young, Mathias Bressel, Sandro Porceddu, et al.
Leukemia & Lymphoma|July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantSimon J Harrison, Andy K Hsu, Paul Neeson, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Haematologica|June 19, 2009
The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cellsPatries M Herst, Joanne E Davis, Paul Neeson, et al.
Virology|August 15, 2006
A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotypePaul Neeson, Jean Boyer, Sanjeev Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in miceJoanne E Davis, Michael Harvey, Nicholas A Gherardin, et al.
Cancers|June 18, 2020
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient SurvivalDonald Freudenstein, Cassandra Litchfield, Franco Caramia, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Immunological responses to brain metastasis stereotactic radiosurgery in patient-matched longitudinal blood and tumour samplesJoseph Sia, Criselle D'Souza, Becky Castle, et al.
Journal of Personalized Medicine|November 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision TherapeuticsJoshua M L Casan, Xiao Jing Ong, Carrie van der Weyden, et al.
Blood|October 28, 2010
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapyAndy K Hsu, Hang Quach, Tsin Tai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2014
Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone lossJulie M Quach, Maria Askmyr, Tanja Jovic, et al.
Oral Oncology|December 16, 2019
Validation and characterisation of prognostically significant PD-L1<sup>+</sup> immune cells in HPV+ oropharyngeal squamous cell carcinomaRichard J Young, Mathias Bressel, Sandro Porceddu, et al.
Leukemia & Lymphoma|July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantSimon J Harrison, Andy K Hsu, Paul Neeson, et al.
Pageof 4